Psychopharmacological treatment of adolescent and adult attention deficit hyperactivity disorder

Irish Journal of Psychological Medicine

Volumn 18, Issue 3, 2001, Pages 93-98

  Fitzgerald, M ^a  

^a Child and Family Centre Dublin   (Ireland)

Author keywords

Attention Deficit Hyperactivity Disorder; Unlicensed medications

Indexed keywords

AMFEBUTAMONE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ATOMOXETINE; BUSPIRONE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DESIPRAMINE; EPHEDRINE; GUANETHIDINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ATTENTION DEFICIT DISORDER; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TOXICITY; HEREDITY; HUMAN; INSOMNIA; IRRITABILITY; NEUROPSYCHOLOGICAL TEST; PSYCHOPHARMACOTHERAPY; RELIABILITY; REVIEW;

EID: 0034841319     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700006480     Document Type: Review

References (48)

1. Attention Deficit Hyperactivity Disorder and co-morbid substance use disorders in adults
2. Attention Deficit Hyperactivity Disorder adults: Comorbidities and adaptive impairments
3. Attention deficit hyperactivity disorder in adults
4. Is attention deficit hyperactivity disorder in adults a valid disorder?
5. The use of psychostimulants in general psychiatry
6. ADHD adult evaluation in private practice: What is sufficient and cost effective
7. A clinical and demographic profile of a sample of adults with Attention Deficit Hyperactivity Disorder, residual state
8. Treating Attention Deficit disorders in children and adults
9. Development of a more reliable version of the Matching Familiar Figures Test
10. A twin study of hyperactivity
11. Association of attention deficit disorder and the dopamine transporter gene
12. Further evidence for family genetic risk factors in Attention Deficit Hyperactivity Disorder
13. Confirmation of association between Attention Deficit Disorder and a Dopamine transporter polymorphism
14. Mapping susceptibility loci in Attention Deficit Hyperactivity Disorder: Preferential transmission of parental alleles at Dat1, DBH, DRD5 to affected children
15. Prescriptions, licenses and evidence: A reply
16. The first choice treatment is still Ritalin. A control study of methylphenidate in the treatment of Attention Deficit Disorder, residual type in adults
17. What's new in stimulant treatment of Attention Deficit Hyperactivity Disorder
18. Double-blind crossover trial of Methylphenidate in placebo in adults with childhood onset Attention Deficit Hyperactivity Disorder
19. Methylphenidate treatment for cocaine abusers with adult Attention Deficit Hyperactivity Disorder: A pilot study
20. Prevalence of adult Attention Deficit Hyperactivity Disorder among cocaine abusers seeing treatment
21. ADHD, the DEA and you
22. Bupropion treatment of attention deficit hyperactivity disorder in adults
23. Six week double blind, placebo controlled study of Desipramine for adult ADHD
24. Clonidine in child and adolescent psychiatry
25. Combing merhylphenidate and clonidine
26. An open label trial of venlafaxine in adult patients with ADHD
27. Venlafaxine versus stimulant therapy in patients with dual diagnosis of Attention Deficit Disorder and Depression
28. A dual-action antidepressant
29. Risperidone in co-morbid ADHD and Oppositional Defiant Disorder / Conduct Disorder
30. A cholinergic agonist for Attention Deficit Hyperactivity Disorder: A pilot controlled clinical trial of ABT - 418 in adults
31. Attention Deficit Hyperactivity Disorder in the prison population
32. Association between ADHD and the dopamine beta hydroxylase gene
33. Nicotinic acetylcholine receptor Alfa 4 sub unit gene polymorphisms and Attention Deficit Hyperactivity Disorder
34. Fundamentals of child psychopharmacology
35. Unlicensed and off label drug use for children with child psychiatric problems